Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
7.27
+0.61 (9.16%)
At close: Jun 9, 2026, 4:00 PM EDT
7.26
-0.01 (-0.14%)
After-hours: Jun 9, 2026, 7:42 PM EDT
Unicycive Therapeutics Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Unicycive Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $41.3. The average 1-year stock price forecast is 468.09% higher than the current stock price, while the lowest is $18 (+147.59%) and the highest is $90 (+1,137.96%).
Price Target: $41.3 (+468.09%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Unicycive Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 7 | 7 | 7 | 8 | 8 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 9 | 9 | 9 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark Co. | Benchmark Co. | Buy Maintains $15 → $18 | Buy | Maintains | $15 → $18 | +147.59% | Jun 2, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $90 | Buy | Maintains | $90 | +1,137.96% | Jun 2, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $22 | Buy | Reiterates | $22 | +202.61% | May 27, 2026 |
| Noble Financial | Noble Financial | Buy Reiterates $60 | Buy | Reiterates | $60 | +725.31% | May 13, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $40 → $37 | Buy | Maintains | $40 → $37 | +408.94% | May 13, 2026 |
Financial Forecast
Revenue This Year
17.83M
Revenue Next Year
346.25M
from 17.83M
Increased by 1,841.85%
EPS This Year
-0.98
from -1.67
EPS Next Year
6.04
from -0.98
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 81.6M | ||
| Avg | 17.8M | ||
| Low | 4.0M |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | 6,284.5% | |
| Avg | 1,841.8% | |
| Low | 421.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.46 | ||
| Avg | -0.98 | ||
| Low | -1.61 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |